US Stock MarketDetailed Quotes
RLAY Relay Therapeutics
- 6.800
- +0.220+3.34%
Close Oct 11 16:00 ET
- 6.604
- -0.197-2.89%
Post 20:01 ET
1.10BMarket Cap-2698P/E (TTM)
6.980High6.460Low2.71MVolume6.520Open6.580Pre Close18.16MTurnover2.20%Turnover RatioLossP/E (Static)162.46MShares12.14052wk High1.62P/B838.03MFloat Cap5.70052wk Low--Dividend TTM123.24MShs Float64.370Historical High--Div YieldTTM7.90%Amplitude5.700Historical Low6.701Avg Price1Lot Size
Relay Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 4.03%-65.83M | 25.04%-50.32M | -30.86%-300.32M | -56.25%-89.19M | -13.99%-75.4M | -20.16%-68.6M | -36.52%-67.13M | -208.43%-229.49M | -43.75%-57.08M | -24.34%-66.15M |
| Net income from continuing operations | 6.39%-92.21M | 13.64%-81.39M | -17.72%-341.97M | -23.69%-83.5M | 21.91%-65.73M | -28.28%-98.51M | -51.89%-94.24M | 20.16%-290.51M | -0.07%-67.5M | -38.36%-84.17M |
| Depreciation and amortization | 2.55%1.37M | 16.54%1.4M | 27.58%5.27M | 17.92%1.38M | 31.95%1.36M | 39.54%1.33M | 22.77%1.2M | 5.22%4.13M | 12.77%1.17M | 2.08%1.03M |
| Other non cash items | -428.53%-11.37M | -82.65%-1.83M | 45.00%-6.42M | 80.40%-2.07M | -136.79%-1.2M | -1,176.00%-2.15M | 78.17%-1M | -108.48%-11.68M | -1,361.24%-10.54M | 63.10%3.26M |
| Change In working capital | 35.03%12.84M | 7.61%7.98M | -388.62%-32.46M | -423.38%-20.6M | -8,702.75%-28.79M | 234.22%9.51M | 214.55%7.41M | -88.45%11.25M | -57.48%6.37M | 96.14%-327K |
| -Change in receivables | --0 | --0 | 1,970.61%5.22M | 306.86%211K | -104.62%-133K | 4,961.32%5.15M | -100.00%-12K | -100.36%-279K | -188.70%-102K | 88.87%-65K |
| -Change in prepaid assets | 74.65%4.64M | -3,068.75%-475K | -117.20%-4.65M | -92.66%955K | 47.09%-8.27M | 3,117.05%2.66M | -97.17%16K | 20.18%-2.14M | 191.51%13.02M | -29.11%-15.64M |
| -Change in payables and accrued expense | 508.42%7.88M | 15.84%8.1M | -256.67%-34.54M | -308.56%-22.09M | -192.07%-20.74M | -58.20%1.3M | 282.03%7M | 0.52%22.05M | -152.23%-5.41M | 438.18%22.52M |
| -Change in other current assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in other working capital | -19.80%328K | -15.66%350K | 118.01%1.51M | 128.60%326K | 105.02%359K | 805.17%409K | 1,320.59%415K | -3,125.27%-8.38M | -2,578.26%-1.14M | -15,984.44%-7.15M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 4.03%-65.83M | 25.04%-50.32M | -30.86%-300.32M | -56.25%-89.19M | -13.99%-75.4M | -20.16%-68.6M | -36.52%-67.13M | -208.43%-229.49M | -43.75%-57.08M | -24.34%-66.15M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -11.17%45.55M | -86.02%10.53M | 236.50%257.63M | 140.61%59.68M | 162.50%71.37M | 18.18%51.28M | 167.01%75.31M | 60.64%-188.75M | 49.81%-146.94M | 30.79%27.19M |
| Net PPE purchase and sale | 99.27%-11K | 7.05%-1.78M | 54.47%-4.13M | 94.91%-118K | 71.84%-590K | 19.06%-1.5M | 31.46%-1.92M | -161.08%-9.06M | -163.18%-2.32M | -20.68%-2.1M |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net investment purchase and sale | -13.68%45.56M | -84.06%12.31M | 245.68%261.76M | 141.35%59.8M | 145.73%71.96M | 16.65%52.78M | 170.47%77.23M | 60.14%-179.68M | 50.44%-144.62M | 29.53%29.28M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -11.17%45.55M | -86.02%10.53M | 236.50%257.63M | 140.61%59.68M | 162.50%71.37M | 18.18%51.28M | 167.01%75.31M | 60.64%-188.75M | 49.81%-146.94M | 30.79%27.19M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -25.87%1.54M | 3,671.94%48.92M | -88.01%34.75M | 1,779.76%21.92M | -96.69%9.46M | 4.21%2.08M | 46.89%1.3M | -25.30%289.91M | -99.70%1.17M | 31,592.35%285.87M |
| Net common stock issuance | --0 | --47.74M | -89.37%30.28M | --20.92M | --9.36M | --0 | --0 | -25.50%284.74M | --0 | ---- |
| Proceeds from stock option exercised by employees | -25.87%1.54M | -8.48%1.19M | -13.43%4.47M | -14.24%1M | -91.53%95K | 4.21%2.08M | 46.89%1.3M | -12.14%5.17M | -35.29%1.17M | 24.28%1.12M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -25.87%1.54M | 3,671.94%48.92M | -88.01%34.75M | 1,779.76%21.92M | -96.69%9.46M | 4.21%2.08M | 46.89%1.3M | -25.30%289.91M | -99.70%1.17M | 31,592.35%285.87M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.05%155.57M | -5.14%146.44M | -45.39%154.37M | -56.88%154.04M | 34.71%148.61M | 34.28%163.85M | -45.39%154.37M | -36.97%282.7M | 54.55%357.22M | -58.00%110.31M |
| Current changes in cash | -22.94%-18.74M | -3.70%9.13M | 93.82%-7.93M | 96.26%-7.59M | -97.80%5.43M | -30.19%-15.24M | 105.90%9.48M | 22.62%-128.33M | -493.42%-202.85M | 883.58%246.91M |
| End cash Position | -7.92%136.83M | -5.05%155.57M | -5.14%146.44M | -5.14%146.44M | -56.88%154.04M | 34.71%148.61M | 34.28%163.85M | -45.39%154.37M | -45.39%154.37M | 54.55%357.22M |
| Free cash flow | 6.08%-65.84M | 24.54%-52.1M | -27.62%-304.44M | -50.36%-89.31M | -11.35%-75.99M | -18.92%-70.1M | -32.86%-69.05M | -206.32%-238.55M | -46.34%-59.4M | -24.22%-68.24M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data